Company profile for Gubra

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Founded in 2008, we are a privately-held biotech company with two primary areas of business: Pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs. Our focus is the metabolic space (obesity, diabetes, NASH and diabetic complications) where we specialize in in vivo pharmacology, peptide chemistry, molecular pharmacology, histology, 3D imaging, stereology, NGS (next generation se...
Founded in 2008, we are a privately-held biotech company with two primary areas of business: Pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs. Our focus is the metabolic space (obesity, diabetes, NASH and diabetic complications) where we specialize in in vivo pharmacology, peptide chemistry, molecular pharmacology, histology, 3D imaging, stereology, NGS (next generation sequencing), bioinformatics and ex vivo assays. We work with some of the most interesting and loyal partners and customers from across the world within big pharma, biotech and academia.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Denmark
Address
Address
Hørsholm Kongevej 11B 2970 Hørsholm
Telephone
Telephone
+45 3152 ­2650
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-11-07/trading-statement-q3-2025-expanding-our-rd-activities

PHARMIWEB
07 Nov 2025

https://www.pharmiweb.com/press-release/2025-11-07/reporting-of-transactions-made-by-persons-discharging-managerial-responsibilities-and-persons-closel

PHARMIWEB
07 Nov 2025

https://www.pharmiweb.com/press-release/2025-11-06/record-earnings-for-gubra-revised-outlook-for-the-cro-business

PHARMIWEB
06 Nov 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/gubra-announces-completion-of-solar-and-battery-park-1067555

ACCESSWIRE
02 Sep 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/interim-report-h1-2025-group-revenue-and-earnings-record-high-1063684

ACCESSWIRE
21 Aug 2025

https://www.pharmiweb.com/press-release/2025-08-20/record-quarter-for-gubra-but-revised-outlook-for-the-cro-business

PHARMAWEB
20 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty